CAG
RecoveryPreclinicalAlso known as: CAG peptide, Collagen-derived peptide, Gly-Hyp-Pro related peptide
CAG (often referring to a collagen-derived or cartilage-targeting peptide sequence) is a short research peptide studied for connective tissue and joint applications. In the context of research peptide vendors, CAG refers to a specific short peptide sequence with proposed activity in cartilage and collagen tissue modulation.
Overview
At A Glance
CAG peptide is proposed to modulate chondrocyte behavior and extracellular matrix components in cartilage tissue. Short collagen-derived peptides (Pro-Hyp, Gly-Pro-Hyp) have documented activity in stimulating hyaluronic acid production and collagen synthesis in chondrocytes and f…
Overview
CAG (often referring to a collagen-derived or cartilage-targeting peptide sequence) is a short research peptide studied for connective tissue and joint applications. In the context of research peptide vendors, CAG refers to a specific short peptide sequence with proposed activity in cartilage and collagen tissue modulation. CAG peptide research is in early preclinical stages with limited published clinical data. It is often compared to other joint/connective tissue peptides like BPC-157, TB-500, and the Khavinson bioregulator Cartalax. The precise mechanism depends on the specific sequence sold by a given vendor.
Chemical Information
IUPAC Name
Not yet available
CAS Number
Not yet available
Molecular Formula
Not yet available
Molecular Mass
Not yet available
Chemical data is being compiled for this compound.
Dosing & Protocols
Unlock Dosing Protocols
Free account gets you:
- View beginner, intermediate & advanced protocols
- See weight-based dosing calculations
- Access cycle length & frequency data
2,800+ researchers already in
Research
Unlock Research Data
Free account gets you:
- Browse PubMed study summaries
- See clinical trial phases & results
- Access mechanism of action details
2,800+ researchers already in
Interactions
Interaction and contraindication data is being compiled for CAG. Check back soon.
General Safety Note
Always consult a qualified healthcare professional before combining research compounds. Interactions may exist that are not yet documented.
No listings found for CAG.
Tracking since Apr 22, 2026 · 2 data points
Related Compounds
View AllARA-290
RecoveryPreclinicalARA-290, also known as Cibinetide or pHBSP (Helix B Surface Peptide), is an 11-amino-acid peptide — QEQLERALNSS — designed to mimic a specific region of the tissue-protective surface of erythropoietin (EPO) without activating the classical hematopoietic EPO receptor that drives red blood cell production.
BPC-157/TB-500 Blend
RecoveryPreclinicalCombined healing peptide blend.
Bronchogen
RecoveryPreclinicalBronchogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
Cardiogen
RecoveryPreclinicalCardiogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
Cartalax
RecoveryPreclinicalCartalax is a short synthetic peptide developed in Russia by Vladimir Khavinson and colleagues at the St.
Chonluten
RecoveryPreclinicalChonluten is a bioregulator preparation originating from Vladimir Khavinson's St.
View Full Dosage Guide →
Protocols, calculator & safety for CAG
Research Score
0 PubMed studies
Quality Indicators
Data Completeness
50%Quick Facts
Half-Life
Unknown
Administration
Subcutaneous, Intraarticular
Trial Phase
Preclinical
Safety Profile
Common Side Effects
- • Limited adverse event data available
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
Frequently Asked Questions
What is CAG used for in research?
CAG (often referring to a collagen-derived or cartilage-targeting peptide sequence) is a short research peptide studied for connective tissue and joint applications. In the context of research peptide vendors, CAG refers to a specific short peptide sequence with proposed activity in cartilage and collagen tissue modulation. CAG peptide research is in early preclinical stages with limited published clinical data. It is often compared to other joint/connective tissue peptides like BPC-157, TB-500, and the Khavinson bioregulator Cartalax. The precise mechanism depends on the specific sequence sold by a given vendor.
What forms does CAG come in?
CAG is available in vials, capsules, and sprays forms.
How much does CAG cost?
Pricing varies by vendor and form.
How do I compare CAG vendors?
Compare prices, payment methods, shipping, and COA scores across 0 vendors.
Research Tools
Related Compounds
View AllARA-290
RecoveryPreclinicalARA-290, also known as Cibinetide or pHBSP (Helix B Surface Peptide), is an 11-amino-acid peptide — QEQLERALNSS — designed to mimic a specific region of the tissue-protective surface of erythropoietin (EPO) without activating the classical hematopoietic EPO receptor that drives red blood cell production.
BPC-157/TB-500 Blend
RecoveryPreclinicalCombined healing peptide blend.
Bronchogen
RecoveryPreclinicalBronchogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
Cardiogen
RecoveryPreclinicalCardiogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
Cartalax
RecoveryPreclinicalCartalax is a short synthetic peptide developed in Russia by Vladimir Khavinson and colleagues at the St.
Chonluten
RecoveryPreclinicalChonluten is a bioregulator preparation originating from Vladimir Khavinson's St.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
